Palliative Radiotherapy to Dominant Symptomatic Lesion in Patients With Hormone Refractory Prostate Cancer
Condition(s):Hormone-refractory Prostate CancerLast Updated:September 12, 2018Unknown status
Hide Studies Not Open or Pending
Condition(s):Hormone-refractory Prostate CancerLast Updated:September 12, 2018Unknown status
Condition(s):Hormone-Refractory Prostate CancerLast Updated:September 8, 2010Completed
Condition(s):Hormone Refractory Prostate CancerLast Updated:December 15, 2011Completed
Condition(s):Hormone-refractory Prostate CancerLast Updated:March 25, 2016Completed
Condition(s):Hormone Refractory Prostate CancerLast Updated:August 14, 2017Completed
Condition(s):Prostate CancerLast Updated:April 3, 2019Completed
Condition(s):Prostate CancerLast Updated:November 29, 2023Completed
Condition(s):Hormone Refractory Prostate Cancer; Bone MetastasesLast Updated:May 27, 2016Completed
Condition(s):Prostate CancerLast Updated:August 17, 2012Terminated
Condition(s):Hormone Refractory Prostate CancerLast Updated:November 9, 2010Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.